The Instruction of 1-(6-Chloro-pyridazin-3-yl)-piperidin-4-ylaMine hydrochloride, 98+% C9H14Cl2N4, MW: 249.14

1-(6-Chloro-pyridazin-3-yl)-piperidin-4-ylaMine hydrochloride, also known as CAS 148647-46-1, is an organic compound that is widely used in the pharmaceutical industry as a research tool for studying the central nervous system.
This compound is a derivative of piperidine, which is a synthetic chemical that is primarily used as a precursor for the production of other chemicals.

The synthesis of 1-(6-Chloro-pyridazin-3-yl)-piperidin-4-ylaMine hydrochloride involves several steps.
The process typically begins with the synthesis of 6-chloro-pyridazine-3-carboxaldehyde, which is then converted into 1-(6-chloro-pyridazin-3-yl)-piperidine through a series of chemical reactions.
Finally, the piperidine compound is hydrolyzed to produce the final product, 1-(6-chloro-pyridazin-3-yl)-piperidin-4-ylaMine hydrochloride.

This compound is typically synthesized in a laboratory setting, using specialized equipment and chemical reagents.
The process requires a high degree of technical expertise and knowledge of organic chemistry, as well as a thorough understanding of the safety precautions that are necessary when handling chemicals of this nature.

One of the key advantages of 1-(6-Chloro-pyridazin-3-yl)-piperidin-4-ylaMine hydrochloride is its ability to act as a potent and selective antagonist at the serotonin 5-HT2A receptor.
This property makes it a valuable tool for researchers who are studying the role of serotonin in the central nervous system, as well as its potential therapeutic uses.

In addition to its use as a research tool, 1-(6-Chloro-pyridazin-3-yl)-piperidin-4-ylaMine hydrochloride is also being investigated for its potential therapeutic applications.
It has been shown to have anxiolytic and antipsychotic effects in animal models, and it is being studied as a potential treatment for a range of neuropsychiatric disorders, including anxiety, depression, and schizophrenia.

Despite its potential therapeutic benefits, the use of 1-(6-Chloro-pyridazin-3-yl)-piperidin-4-ylaMine hydrochloride is still in the early stages of development, and much more research is needed to fully understand its safety and efficacy.
Nonetheless, it is clear that this compound holds great promise as a potential treatment for a range of neuropsychiatric disorders, and it will likely continue to be a subject of interest in the pharmaceutical industry for years to come.

In conclusion, 1-(6-Chloro-pyridazin-3-yl)-piperidin-4-ylaMine hydrochloride is an important organic compound that is widely used in the pharmaceutical industry as a research tool.
Its ability to act as a potent and selective antagonist at the serotonin 5-HT2A receptor makes it a valuable tool for researchers who are studying the role of serotonin in the central nervous system.
Additionally, it has been shown to have anxiolytic and antipsychotic effects in animal models, and it holds great promise as a potential treatment for a range of neuropsychiatric disorders.
However, much more research is needed to fully understand its safety and efficacy, and its use is still in the early stages of development.
Nonetheless, it is clear that this